Drawing for REZNARE

USPTO serial 97201460

REZNARE

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
BIFTU, BENIAM
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with REZNARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Janina Gorbach

Janina Gorbach Pfizer Inc.66 Hudson Boulevard EastNew York, NY 10001-2192United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparationsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 9, 2025MAB5ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION—
Sep 9, 2025ABN5ABANDONMENT - AFTER PUBLICATION—
Sep 8, 2025EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Aug 28, 2025EX5GSOU EXTENSION 5 GRANTED—
Aug 28, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 24, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 23, 2025EXT5SOU EXTENSION 5 FILED—
Oct 31, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 31, 2024EX4GSOU EXTENSION 4 GRANTED—
Oct 31, 2024EXT4SOU EXTENSION 4 FILED—
Oct 31, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 26, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 25, 2024EX3GSOU EXTENSION 3 GRANTED—
Apr 25, 2024EXT3SOU EXTENSION 3 FILED—
Apr 25, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 4, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 2, 2023EX2GSOU EXTENSION 2 GRANTED—
Nov 2, 2023EXT2SOU EXTENSION 2 FILED—
Nov 2, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 17, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 15, 2023EX1GSOU EXTENSION 1 GRANTED—
May 15, 2023EXT1SOU EXTENSION 1 FILED—
May 15, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 27, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 27, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 27, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 27, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 27, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 13, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 18, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 18, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 28, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 14, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 14, 2022DOCKASSIGNED TO EXAMINER—
Jan 7, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 7, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance